Dialogues
Healthcare
The HEAD Foundation Dialogues provides a dynamic platform for discussions among thought leaders to exchange ideas and perspectives around salient issues in education, healthcare, human capital, and leadership development.
Issue 135: Lecanemab – A silver lining for patients with Alzheimer’s
Alzheimer’s disease, which accounts for 60-70% of dementia cases worldwide, may soon be treatable. The newest experimental drug, lecanemab, developed by pharmaceutical…
Philosophy of Ageing — The Art, Science and Good News of Ageing (Part 5)
For the final session of the five-part series “The Art, Science and Good News of Ageing” on 7 December, Dr…
TCM for Ageing — The Art, Science and Good News of Ageing (Part 4)
How does Traditional Chinese Medicine (TCM) assist in healthy ageing? In the fourth instalment of the five-part series “The Art,…
Getting Age-Prepared — The Art, Science and Good News of Ageing (Part 3)
In the third instalment of the five-part series “The Art, Science and Good News of Ageing” on 16 November, Prof Wong…